Enteral Medical Nutrition Market

Enteral Medical Nutrition Market Outlook (2022-2032)

The enteral medical nutrition market is likely to expand its roots at a CAGR of 5.8% during the forecast period of 2022-2032. The market holds a value of 8,256.05 million in 2022, while it is anticipated to cross a revenue of US$ 14,508 million by 2032.

Enteral medical nutrition involves feeding through the gastrointestinal tract to provide calories and nutrition. The form of nutrition is delivered as a liquid through tube feeding or directly consuming it. Numerous nutrition beverages and formulas help patients with different deficiencies get enough nutrients.

Patients suffering from various chronic diseases and poor appetites are unable to eat enough food and require additional nutrients, expanding the enteral medical nutrition market size. Enteral medical nutrition beverages help patients that suffer from illnesses and can’t consume nutritional food. Thus, government programs and medical workshops help in spreading awareness about the application of NG tubes for nutritional delivery.

Healthcare facilities demand tools that can easily deliver nutrients to the patient going through treatment or are on a ventilator. Early nutritional support in the form of enteral nutrition delivers important benefits in terms of the interaction between the gut and systemic immune response in chronically ill patients. The outcome of its applications helps in maintaining gut integrity and physiologic stress response, increasing its adoption in healthcare services.

Crohn’s disease is a complex chronic disorder that majorly affects the digestive system. More than half a million North American and Western European citizens suffer from the disease. Enteral medical nutrition is delivered through the tube-feeding process.

The rising cases of gastrointestinal disease due to nutritional deterioration is common among US citizens. The diagnostic tests, appetite loss, and therapeutic dietary restriction fuel the demand for enteral medical nutrition.

Rising cases of strokes, cancer, and critical illness or injuries trigger the impairment of swallowing capability along with fatigue, nausea, and vomiting. Therefore, enteral medical nutrition.

Report Attributes	Details
Market Size (2022)	USD 8,256.05 Million
Projected Market Value (2032)	USD 14,508 Million
Global Market Growth Rate	5.8%
Cancer Indication Segment Market CAGR	7.4%
Key Companies Profiled	Abbott Laboratories Nutricia Fresenius Kabi AG B. Braun Melsungen AG NESTLE S.A. Meiji Holdings Co., Ltd. Smartfish AS; DSM Hormel Foods Corporation Global Health Products, Inc.

Various feeding solutions for the enteral medical nutrition delivery

The diversification of the enteral medical nutrition system involves six different types of enteral nutrition feeding practices. These tubes involve further subtypes depending on exactly where they end the stomach or intestines. Medical healthcare services adopt the enteral nutrition systems that enter through the different entrances. Thus, vendors adopt these different delivery tools.

Nasogastric Tube (NGT) :-

While the nasogastric tube is a thin and flexible tube that is inserted inside the nose while it travels down the esophagus into the stomach to carry nutritional food items in the form of liquid, it can be used for all feedings or for giving a person extra calories. The facilities that deal with chronic patients along with the patients having to sever injuries.

Orogastric Tube (OGT) :- 

The only difference between OG and NG tubes is the OG tube is inserted from the mouth as it enters the stomach. This is considered the best for patients suffering from injuries in the nose or the windpipe is blocked. These tubes also help in removing the air from the baby’s stomach.

Boasting cases of Cachexia fuels the demand for the Enteral

Cachexia is a multifunctional disease that causes extreme weight loss, skeletal muscle and adipose tissue loss, metabolic regulation imbalance, and food intake reduction. The condition occurs in patients that suffer from chronic kidney and heart diseases. While cancer cachexia negatively impacts the quality of life. This involves trouble in eating and consuming any food item. Therefore, the rising cases of cachexia are driving the higher adoption of enteral medical nutrition delivery systems.

WHO recorded 10 million deaths and 15.6 million new cases of cancer in 2020. Thus, people with severe ere symptoms require additional food nutrients support that is provided through the enteral medical nutrition supply.

Segmentation Insights

What Indication Type Accounts for Most Revenue Generation in the Enteral Medical Nutrition Market?

The respiratory disorders segment tops the indication category with a CAGR of 7.4% during the forecast period. The factors driving the growth of this segment are the increasing population leading people to get more respiratory diseases. Respiratory diseases lead to the lack of oxygen reaching the mind, which further affects functioning and ends up as a stroke.

Therefore, patients adopting enteral medical nutrition solutions are majorly suffering from respiratory illness. Abbott has recently introduced its supplement named pulmonary, which carries high-calorie, modified carbohydrates for patients suffering from COPD and respiratory failure. Other than this, the respiratory segment is further divided into chronic obtrusive pulmonary disease (COPD), respiratory failure, cystic fibrosis, and others.

Why is Supplement Segment a leading Nutrition Type Segment in Enteral medical nutrition Industry?

The supplemental segment will hold a larger market share in 2022, while the sole-source segment is anticipated to register a higher CAGR during the forecast period. The patients that receive the supplemental source of nutrition are subjected to stay within the hospital for a prolonged period.

Healthcare facilities are focusing on adopting nutrition that helps a larger set of patients that have different indications but a common nutritional requirement. These are the nutritional formulas that are rich in Omega-3, glutamine, ribonucleic acids, and fatty acids. These elements help the patient in the fulfillment of their diet while also healing their body at a slow rate.

Which Product type is Poised to Drive Enteral Medical Nutrition Market

The standard protein diet segment held the largest share of the market in 2022. However, the fruit juice-based oral nutrient segment is anticipated to register the highest CAGR during the forecast period. Other segments involve standard protein diet, high protein diet, fruit juice-based oral nutrients, etc.

Country Insights

How Will the U.S. Enteral Medical Nutrition Market Evolve?

The US government is launching multiple initiatives to boost the market. For example, the Feeding Tube Awareness Foundation is creating awareness about feeding tube adoption. This also integrates with the natal care movement running across the country as the tube-feeding becomes a part of natal care in cases of complications.

North America dominated the enteral medical nutrition market in 2021. Therefore, the increasing number of US FDA approvals for enteral nutrition products would drive the market growth during the forecast period (2022-2032)

Lucrative growth in Asia Pacific region is led by the Geriatric Population Rise

Asia-Pacific has become a lucrative space for opportunities involving key players operating in the enteral nutrition market, attributing to an increase in the patient population suffering from diseases such as cancer, neurological disorders, gastrointestinal disorders, diabetes, and other chronic conditions.

The Asia-pacific region has a huge population that lies between the age of 12-30. The new geriatric population has a low immune system and even lower nutrition quotient. Therefore, the increase in the geriatric population in emerging economies, the development of the R&D sector,

Why is China's Enteral medical nutrition Market Growing the Fastest Among Major Economies?

Growth is expected to be driven by rising demand for diagnostic products, as well as rising healthcare expenditures, over the forecast period. The growing geriatric population, rising chronic disease incidences, and increased development of advanced products are expected to drive market growth.

The Japanese Market to Expand Rapidly in the Coming Years

The Enteral medical nutrition industry growth is being driven by on-going medical infrastructure expansion as well as increased government and private sector investments to promote the use of safer and more cost-effective healthcare solutions.

Comparative View of Adjacent Enteral medical nutrition Industry

Enteral Medical Nutrition Industry:

Attributes	Enteral Medical Nutrition Market
CAGR (2022-2032)	5.8%
Market Value (2027)	US$ 10.94 Bn
Growth Factor	Rising cases of cancer followed by advent of covid-19 and rise of respiratory diseases have led the healthcare services adopt the enteral medical nutrition as supplements and beverage supply.
Opportunity	The advanced nutritional supply targets patients with special diseases and largely provides support to the digestive system with higher proteins, acids, and other fluids.
Key Trends	The enteral medical nutrition supplies coming with caloric densities of 1.0, 1.2, 1.5 are the latest addition that trends among the vendors.

Skin Cancer Diagnostics & Therapeutics Market :

Attributes	Skin Cancer Diagnostics & Therapeutics Market
CAGR (2022-2032)	10%
Market Value (2027)	US$ 11.6 Bn
Growth Factor	Pollution and direct exposition to the UV rays is leading to the rising number of skin cancer patients in the various parts of the countries, pushing the skin cancer diagnostics & therapeutics market upward.
Opportunity	New advanced versions and stages are a challenge that creates multiple opportunities for the skin cancer diagnostics & therapeutics market to experiment and diversify their approach.
Key Trends	To get into multiple layers of symptoms, followed by the first line protocol while integrating with Artificial intelligence and machine learning.

Oncology Market :

Attributes	Oncology Market
CAGR (2022-2032)	8%
Market Value (2027)	US$ 378 Bn
Growth Factor	Rising awareness regarding cancer and availability of various oncology treatments and innovative diagnostic tools, fueling the demand for oncology analysts.
Opportunity	The market creates opportunities for the component markets like cancer diagnosis and therapeutic, helping them find their space in the market race.
Key Trends	The machine learning and internet of things (IOT) integrate with oncology tools to make it easy and accurate are flourishing the trends of oncology market.

Competitors Landscape

Competitors in enteral medical nutrition market are focusing on providing the wholesome liquid supply that involves all the nutrients such as fatty acids, and ribonucleic acids. To further strengthen their position in the market, the market players are implementing a variety of strategies, including mergers and acquisitions, partnerships, innovations, and product launches, such as the launch of osmometer products.

The enteral medical nutrition market is extremely fragmented, with many of the players being local or regional. Players in the market are concentrating on launching cutting-edge products and expanding geographically.

Recent Development :

Date	Company Name	Strategy	Details
June 2022	Abott	Introduction	Abbott Healthcare has introduced a long range of medical nutrition supplies for all the ages ranging from kids to elder people. The range of products involve Ensure (Provides strength and energy to the patient), Elecare (Amino Acid-based formula), Glucerna (Delicious meal or snack replacement). Abbott has recently introduced its supplement named pulmore which carries high-calorie, modified carbohydrates for patients suffering from COPD, and respiratory failure.
September 2021	Fresenius-Kabi	Introduction	Fresenius-Kabi have reshaped and revisited its long range of ENLocks, feeding pumps, giving sets along with the enteral medical nutrition supply such as kkabimmune, kabisure, fresubin DM.
September, 2022	Nestle Health Science	Acquisition	Nestlé Health Science acquired Puravida, a premium Brazilian nutrition and health lifestyle brand. The acquisition will enable NHSc to expand its consumer health portfolio in Brazil. Puravida's mix of products complements Nestlé Health Science’s portfolio, which already has an offering in oral nutritional supplements, protein powders, and ready-to-drink nutritional beverages in Brazil.
August 2019	Smartfish AS	Collaboration	Smartfish AS has followed a strategic collaboration with an international healthcare brand B. Braun to secure a global launch of its medical nutrition product Remune. B. Braun have launched Remune in close to 20 countries during 2019–2020, followed by several other markets in Europe, Asia, and South America. The collaboration also generates traction for other potential launches by B. Braun of other innovative products based on Smartfish’s technology.

Key Segments

• By Indication :

  • Respiratory Disorders
  • Cancer
  • Post COVID-19
  • Gastrointestinal Disorders
  • Liver Failure

• By Nutrition Type :

  • Supplemental and
  • Sole-Source

• By Form :

  • Powder
  • Liquid
  • Semi-Solid)

• By Product :

  • Standard Protein Diet
  • High Protein Diet
  • Fruit Juice Based Oral Nutritional Supplement

• By Distribution Channel :

  • Hospital Pharmacies
  • Retail Stores

• By Age Group :

  • Child (Till 18 Years)
  • Adults (18+years)

• By Region :

  • North America
  • Latin America
  • Asia Pacific
  • MEA
  • Europe